[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biosimilar Drug Consumption 2016 Market Research Report

May 2016 | 179 pages | ID: G5EAE505DE0EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Biosimilar Drug Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Biosimilar Drug market.

First, the report provides a basic overview of the Biosimilar Drug industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Secondly, the report states the global Biosimilar Drug market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed.

Third, the Biosimilar Drug market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Biosimilar Drug industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 INDUSTRY OVERVIEW OF BIOSIMILAR DRUG

1.1 Definition and Specifications of Biosimilar Drug
  1.1.1 Definition of Biosimilar Drug
  1.1.2 Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.3 Applications of Biosimilar Drug
1.4 Industry Chain Structure of Biosimilar Drug
1.5 Industry Overview and Major Regions Status of Biosimilar Drug
  1.5.1 Industry Overview of Biosimilar Drug
  1.5.2 Global Major Regions Status of Biosimilar Drug
1.6 Industry Policy Analysis of Biosimilar Drug
1.7 Industry News Analysis of Biosimilar Drug

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOSIMILAR DRUG

2.1 Raw Material Suppliers and Price Analysis of Biosimilar Drug
2.2 Equipment Suppliers and Price Analysis of Biosimilar Drug
2.3 Labor Cost Analysis of Biosimilar Drug
2.4 Other Costs Analysis of Biosimilar Drug
2.5 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.6 Manufacturing Process Analysis of Biosimilar Drug

3 3 GLOBAL MARKET SIZE (VOLUME AND VALUE), SALES AND SALE PRICE ANALYSIS OF BIOSIMILAR DRUG

3.1 Global Market Size (Volume and Value) and Growth Rate of Biosimilar Drug 2011-2016
3.2 Global Market Size (Volume and Value) of Biosimilar Drug by Regions 2011-2016
3.3 Global Market Size (Volume and Value) of Biosimilar Drug by Types 2011-2016
3.4 Global Market Size (Volume and Value) of Biosimilar Drug by Applications 2011-2016
3.5 Global Sales Volume and Sales Revenue of Biosimilar Drug by Companies 2011-2016
3.6 Global Sale Price of Biosimilar Drug by Regions 2011-2016
3.7 Global Sale Price of Biosimilar Drug by Types 2011-2016
3.8 Global Sale Price of Biosimilar Drug by Applications 2011-2016
3.9 Global Sale Price of Biosimilar Drug by Companies 2011-2016

4 US MARKET SIZE (VOLUME AND VALUE), SALES, SALE PRICE AND END USERS ANALYSIS OF BIOSIMILAR DRUG

4.1 US Market Size (Volume and Value) and Growth Rate of Biosimilar Drug 2011-2016
4.2 US Market Size (Volume and Value) of Biosimilar Drug by Types 2011-2016
4.3 US Market Size (Volume and Value) of Biosimilar Drug by Applications 2011-2016
4.4 US Sales Volume and Sales Revenue of Biosimilar Drug by Companies 2011-2016
4.5 US Sale Price of Biosimilar Drug by Types 2011-2016
4.6 US Sale Price of Biosimilar Drug by Applications 2011-2016
4.7 US Sale Price of Biosimilar Drug by Companies 2011-2016
4.8 US Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
4.9 US End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications

5 EUROPE MARKET SIZE (VOLUME AND VALUE), SALES, SALE PRICE AND END USERS ANALYSIS OF BIOSIMILAR DRUG

5.1 Europe Market Size (Volume and Value) and Growth Rate of Biosimilar Drug 2011-2016
5.2 Europe Market Size (Volume and Value) of Biosimilar Drug by Types 2011-2016
5.3 Europe Market Size (Volume and Value) of Biosimilar Drug by Applications 2011-2016
5.4 Europe Sales Volume and Sales Revenue of Biosimilar Drug by Companies 2011-2016
5.5 Europe Sale Price of Biosimilar Drug by Types 2011-2016
5.6 Europe Sale Price of Biosimilar Drug by Applications 2011-2016
5.7 Europe Sale Price of Biosimilar Drug by Companies 2011-2016
5.8 Europe Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
5.9 Europe End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications

6 JAPAN MARKET SIZE (VOLUME AND VALUE), SALES, SALE PRICE AND END USERS ANALYSIS OF BIOSIMILAR DRUG

6.1 Japan Market Size (Volume and Value) and Growth Rate of Biosimilar Drug 2011-2016
6.2 Japan Market Size (Volume and Value) of Biosimilar Drug by Types 2011-2016
6.3 Japan Market Size (Volume and Value) of Biosimilar Drug by Applications 2011-2016
6.4 Japan Sales Volume and Sales Revenue of Biosimilar Drug by Companies 2011-2016
6.5 Japan Sale Price of Biosimilar Drug by Types 2011-2016
6.6 Japan Sale Price of Biosimilar Drug by Applications 2011-2016
6.7 Japan Sale Price of Biosimilar Drug by Companies 2011-2016
6.8 Japan Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
6.9 Japan End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications

7 CHINA MARKET SIZE (VOLUME AND VALUE), SALES, SALE PRICE AND END USERS ANALYSIS OF BIOSIMILAR DRUG

7.1 China Market Size (Volume and Value) and Growth Rate of Biosimilar Drug 2011-2016
7.2 China Market Size (Volume and Value) of Biosimilar Drug by Types 2011-2016
7.3 China Market Size (Volume and Value) of Biosimilar Drug by Applications 2011-2016
7.4 China Sales Volume and Sales Revenue of Biosimilar Drug by Companies 2011-2016
7.5 China Sale Price of Biosimilar Drug by Types 2011-2016
7.6 China Sale Price of Biosimilar Drug by Applications 2011-2016
7.7 China Sale Price of Biosimilar Drug by Companies 2011-2016
7.8 China Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016
7.9 China End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications

8 MAJOR MANUFACTURERS ANALYSIS OF BIOSIMILAR DRUG

8.1 Hospira
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.1.4 Contact Information
8.2 Sandoz
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.2.4 Contact Information
8.3 Teva Pharmaceutical Industries
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.3.4 Contact Information
8.4 Pfizer
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.4.4 Contact Information
8.5 Merck Sharp & Dohme
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.5.4 Contact Information
8.6 Celltrion
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.6.4 Contact Information
8.7 Amgen
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.7.4 Contact Information
8.8 Biogen
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.8.4 Contact Information
8.9 Mylan
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.9.4 Contact Information
8.10 Biocon
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.10.4 Contact Information
8.11 Dr. Reddy’s Laboratories
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
    8.11.2.1 Type I
    8.11.2.2 Type II
    8.11.2.3 Type III
  8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.11.4 Contact Information
8.12 Boehringer Ingelheim GmbH
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
    8.12.2.1 Type I
    8.12.2.2 Type II
    8.12.2.3 Type III
  8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.12.4 Contact Information
8.13 Intas Pharmaceuticals
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
    8.13.2.1 Type I
    8.13.2.2 Type II
    8.13.2.3 Type III
  8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.13.4 Contact Information
8.14 LG Life Sciences
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
    8.14.2.1 Type I
    8.14.2.2 Type II
    8.14.2.3 Type III
  8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.14.4 Contact Information
8.15 Emcure Pharmaceuticals
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
    8.15.2.1 Type I
    8.15.2.2 Type II
    8.15.2.3 Type III
  8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.15.4 Contact Information
8.16 Probiomed
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
    8.16.2.1 Type I
    8.16.2.2 Type II
    8.16.2.3 Type III
  8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.16.4 Contact Information
8.17 Biosidus
  8.17.1 Company Profile
  8.17.2 Product Picture and Specifications
    8.17.2.1 Type I
    8.17.2.2 Type II
    8.17.2.3 Type III
  8.17.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.17.4 Contact Information
8.18 3SBio
  8.18.1 Company Profile
  8.18.2 Product Picture and Specifications
    8.18.2.1 Type I
    8.18.2.2 Type II
    8.18.2.3 Type III
  8.18.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.18.4 Contact Information
8.19 WOCKHARDT
  8.19.1 Company Profile
  8.19.2 Product Picture and Specifications
    8.19.2.1 Type I
    8.19.2.2 Type II
    8.19.2.3 Type III
  8.19.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.19.4 Contact Information
8.20 Sun Pharmaceutical Industries
  8.20.1 Company Profile
  8.20.2 Product Picture and Specifications
    8.20.2.1 Type I
    8.20.2.2 Type II
    8.20.2.3 Type III
  8.20.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.20.4 Contact Information
8.21 Shanghai Fosun Pharmaceutical
  8.21.1 Company Profile
  8.21.2 Product Picture and Specifications
    8.21.2.1 Type I
    8.21.2.2 Type II
    8.21.2.3 Type III
  8.21.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.21.4 Contact Information
8.22 Qilu Pharmaceutical
  8.22.1 Company Profile
  8.22.2 Product Picture and Specifications
    8.22.2.1 Type I
    8.22.2.2 Type II
    8.22.2.3 Type III
  8.22.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.22.4 Contact Information
8.23 Allergan
  8.23.1 Company Profile
  8.23.2 Product Picture and Specifications
    8.23.2.1 Type I
    8.23.2.2 Type II
    8.23.2.3 Type III
  8.23.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.23.4 Contact Information
8.24 Dongbao
  8.24.1 Company Profile
  8.24.2 Product Picture and Specifications
    8.24.2.1 Type I
    8.24.2.2 Type II
    8.24.2.3 Type III
  8.24.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.24.4 Contact Information
8.25 Samsung Biologics
  8.25.1 Company Profile
  8.25.2 Product Picture and Specifications
    8.25.2.1 Type I
    8.25.2.2 Type II
    8.25.2.3 Type III
  8.25.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.25.4 Contact Information
8.26 Zydus Cadila.
  8.26.1 Company Profile
  8.26.2 Product Picture and Specifications
    8.26.2.1 Type I
    8.26.2.2 Type II
    8.26.2.3 Type III
  8.26.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.26.4 Contact Information
8.27 Dong-A Pharmaceutical
  8.27.1 Company Profile
  8.27.2 Product Picture and Specifications
    8.27.2.1 Type I
    8.27.2.2 Type II
    8.27.2.3 Type III
  8.27.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.27.4 Contact Information

9 GLOBAL PRODUCTION ANALYSIS OF BIOSIMILAR DRUG BY REGIONS

9.1 Global Production of Biosimilar Drug by Regions 2011-2016
9.2 Global Production Market Share of Biosimilar Drug by Regions 2011-2016

10 GLOBAL AND MAJOR REGIONS MARKET SIZE (VOLUME AND VALUE) FORECAST OF BIOSIMILAR DRUG

10.1 Global and Major Regions Market Size (Volume and Value) and Growth Rate of Biosimilar Drug 2016-2021
10.2 Global Market Size (Volume and Value) of Biosimilar Drug by Regions 2016-2021
10.3 Global and Major Regions Market Size (Volume and Value) of Biosimilar Drug by Types 2016-2021
10.4 Global and Major Regions Market Size (Volume and Value) of Biosimilar Drug by Applications 2016-2021

11 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF BIOSIMILAR DRUG

11.1 Marketing Channels Status of Biosimilar Drug
11.2 Traders or Distributors with Contact Information of Biosimilar Drug by Regions
11.3 Regional Import, Export and Trade Analysis of Biosimilar Drug

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF BIOSIMILAR DRUG

12.1 New Project SWOT Analysis of Biosimilar Drug
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug

13 CONCLUSION OF THE GLOBAL BIOSIMILAR DRUG CONSUMPTION 2016 MARKET RESEARCH REPORT
LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Drug
Table Product Specifications of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Global Market Size (Volume) Share of Biosimilar Drug by Types in 2015
Figure Global Market Size (Value) Share of Biosimilar Drug by Types in 2015
Table Applications of Biosimilar Drug
Figure Global Market Size (Volume) Share of Biosimilar Drug by Applications in 2015
Figure Global Market Size (Value) Share of Biosimilar Drug by Applications in 2015
Figure Industry Chain Structure of Biosimilar Drug
Table Global Biosimilar Drug Major Companies
Table Global Major Regions Biosimilar Drug Development Status
Table Industry Policy of Biosimilar Drug
Table Industry News List of Biosimilar Drug
Table Raw Material Suppliers and Price Analysis
Table Equipment Suppliers and Price Analysis
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Global Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure Global Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Table Global Market Size (Volume) (K Dose) of Biosimilar Drug by Regions 2011-2016
Figure Global Market Size (Volume) Share of Biosimilar Drug by Regions in 2011
Figure Global Market Size (Volume) Share of Biosimilar Drug by Regions in 2015
Table Global Market Size (Value) (M USD) of Biosimilar Drug by Regions 2011-2016
Figure Global Market Size (Value) Share of Biosimilar Drug by Regions in 2011
Figure Global Market Size (Value) Share of Biosimilar Drug by Regions in 2015
Table Global Market Size (Volume) (K Dose) of Biosimilar Drug by Types 2011-2016
Figure Global Market Size (Volume) Share of Biosimilar Drug by Types in 2011
Figure Global Market Size (Volume) Share of Biosimilar Drug by Types in 2015
Table Global Market Size (Value) (M USD) of Biosimilar Drug by Types 2011-2016
Figure Global Market Size (Value) Share of Biosimilar Drug by Types in 2011
Figure Global Market Size (Value) Share of Biosimilar Drug by Types in 2015
Table Global Market Size (Volume) (K Dose) of Biosimilar Drug by Applications 2011-2016
Figure Global Market Size (Volume) Share of Biosimilar Drug by Applications in 2011
Figure Global Market Size (Volume) Share of Biosimilar Drug by Applications in 2015
Table Global Market Size (Value) (M USD) of Biosimilar Drug by Applications 2011-2016
Figure Global Market Size (Value) Share of Biosimilar Drug by Applications in 2011
Figure Global Market Size (Value) Share of Biosimilar Drug by Applications in 2015
Table Global Sales Volume (K Dose) of Biosimilar Drug by Companies 2011-2016
Table Global Sales Volume Market Share of Biosimilar Drug by Companies 2011-2016
Figure Global Sales Volume Market Share of Biosimilar Drug by Companies in 2011
Figure Global Sales Volume Market Share of Biosimilar Drug by Companies in 2015
Table Global Sales Revenue (M USD) of Biosimilar Drug by Companies 2011-2016
Table Global Sales Revenue Market Share of Biosimilar Drug by Companies 2011-2016
Figure Global Sales Revenue Market Share of Biosimilar Drug by Companies in 2011
Figure Global Sales Revenue Market Share of Biosimilar Drug by Companies in 2015
Table Global Sale Price (USD/Dose) of Biosimilar Drug by Regions 2011-2016
Figure Global Sale Price (USD/Dose) of Biosimilar Drug by Regions in 2015
Table Global Sale Price (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure Global Sale Price (USD/Dose) of Biosimilar Drug by Types in 2015
Table Global Sale Price (USD/Dose) of Biosimilar Drug by Applications 2011-2016
Figure Global Sale Price (USD/Dose) of Biosimilar Drug by Applications in 2015
Table Global Sale Price (USD/Dose) of Biosimilar Drug by Companies 2011-2016
Figure Global Sale Price (USD/Dose) of Biosimilar Drug by Companies in 2015
Figure US Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure US Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Table US Market Size (Volume) (K Dose) of Biosimilar Drug by Types 2011-2016
Figure US Market Size (Volume) Share of Biosimilar Drug by Types in 2011
Figure US Market Size (Volume) Share of Biosimilar Drug by Types in 2015
Table US Market Size (Value) (M USD) of Biosimilar Drug by Types 2011-2016
Figure US Market Size (Value) Share of Biosimilar Drug by Types in 2011
Figure US Market Size (Value) Share of Biosimilar Drug by Types in 2015
Table US Market Size (Volume) (K Dose) of Biosimilar Drug by Applications 2011-2016
Figure US Market Size (Volume) Share of Biosimilar Drug by Applications in 2011
Figure US Market Size (Volume) Share of Biosimilar Drug by Applications in 2015
Table US Market Size (Value) (M USD) of Biosimilar Drug by Applications 2011-2016
Figure US Market Size (Value) Share of Biosimilar Drug by Applications in 2011
Figure US Market Size (Value) Share of Biosimilar Drug by Applications in 2015
Table US Sales Volume (K Dose) of Biosimilar Drug by Companies 2011-2016
Table US Sales Volume Market Share of Biosimilar Drug by Companies 2011-2016
Figure US Sales Volume Market Share of Biosimilar Drug by Companies in 2011
Figure US Sales Volume Market Share of Biosimilar Drug by Companies in 2015
Table US Sales Revenue (M USD) of Biosimilar Drug by Companies 2011-2016
Table US Sales Revenue Market Share of Biosimilar Drug by Companies 2011-2016
Figure US Sales Revenue Market Share of Biosimilar Drug by Companies in 2011
Figure US Sales Revenue Market Share of Biosimilar Drug by Companies in 2015
Figure US Sale Price (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure US Sale Price (USD/Dose) of Biosimilar Drug by Types in 2015
Table US Sale Price (USD/Dose) of Biosimilar Drug by Applications 2011-2016
Figure US Sale Price (USD/Dose) of Biosimilar Drug by Applications in 2015
Table US Sale Price (USD/Dose) of Biosimilar Drug by Companies 2011-2016
Figure US Sale Price (USD/Dose) of Biosimilar Drug by Companies in 2015
Table US Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table US End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications
Figure Europe Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure Europe Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Table Europe Market Size (Volume) (K Dose) of Biosimilar Drug by Types 2011-2016
Figure Europe Market Size (Volume) Share of Biosimilar Drug by Types in 2011
Figure Europe Market Size (Volume) Share of Biosimilar Drug by Types in 2015
Table Europe Market Size (Value) (M USD) of Biosimilar Drug by Types 2011-2016
Figure Europe Market Size (Value) Share of Biosimilar Drug by Types in 2011
Figure Europe Market Size (Value) Share of Biosimilar Drug by Types in 2015
Table Europe Market Size (Volume) (K Dose) of Biosimilar Drug by Applications 2011-2016
Figure Europe Market Size (Volume) Share of Biosimilar Drug by Applications in 2011
Figure Europe Market Size (Volume) Share of Biosimilar Drug by Applications in 2015
Table Europe Market Size (Value) (M USD) of Biosimilar Drug by Applications 2011-2016
Figure Europe Market Size (Value) Share of Biosimilar Drug by Applications in 2011
Figure Europe Market Size (Value) Share of Biosimilar Drug by Applications in 2015
Table Europe Sales Volume (K Dose) of Biosimilar Drug by Companies 2011-2016
Table Europe Sales Volume Market Share of Biosimilar Drug by Companies 2011-2016
Figure Europe Sales Volume Market Share of Biosimilar Drug by Companies in 2011
Figure Europe Sales Volume Market Share of Biosimilar Drug by Companies in 2015
Table Europe Sales Revenue (M USD) of Biosimilar Drug by Companies 2011-2016
Table Europe Sales Revenue Market Share of Biosimilar Drug by Companies 2011-2016
Figure Europe Sales Revenue Market Share of Biosimilar Drug by Companies in 2011
Figure Europe Sales Revenue Market Share of Biosimilar Drug by Companies in 2015
Figure Europe Sale Price (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure Europe Sale Price (USD/Dose) of Biosimilar Drug by Types in 2015
Table Europe Sale Price (USD/Dose) of Biosimilar Drug by Applications 2011-2016
Figure Europe Sale Price (USD/Dose) of Biosimilar Drug by Applications in 2015
Table Europe Sale Price (USD/Dose) of Biosimilar Drug by Companies 2011-2016
Figure Europe Sale Price (USD/Dose) of Biosimilar Drug by Companies in 2015
Table Europe Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table Europe End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications
Figure Japan Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure Japan Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Table Japan Market Size (Volume) (K Dose) of Biosimilar Drug by Types 2011-2016
Figure Japan Market Size (Volume) Share of Biosimilar Drug by Types in 2011
Figure Japan Market Size (Volume) Share of Biosimilar Drug by Types in 2015
Table Japan Market Size (Value) (M USD) of Biosimilar Drug by Types 2011-2016
Figure Japan Market Size (Value) Share of Biosimilar Drug by Types in 2011
Figure Japan Market Size (Value) Share of Biosimilar Drug by Types in 2015
Table Japan Market Size (Volume) (K Dose) of Biosimilar Drug by Applications 2011-2016
Figure Japan Market Size (Volume) Share of Biosimilar Drug by Applications in 2011
Figure Japan Market Size (Volume) Share of Biosimilar Drug by Applications in 2015
Table Japan Market Size (Value) (M USD) of Biosimilar Drug by Applications 2011-2016
Figure Japan Market Size (Value) Share of Biosimilar Drug by Applications in 2011
Figure Japan Market Size (Value) Share of Biosimilar Drug by Applications in 2015
Table Japan Sales Volume (K Dose) of Biosimilar Drug by Companies 2011-2016
Table Japan Sales Volume Market Share of Biosimilar Drug by Companies 2011-2016
Figure Japan Sales Volume Market Share of Biosimilar Drug by Companies in 2011
Figure Japan Sales Volume Market Share of Biosimilar Drug by Companies in 2015
Table Japan Sales Revenue (M USD) of Biosimilar Drug by Companies 2011-2016
Table Japan Sales Revenue Market Share of Biosimilar Drug by Companies 2011-2016
Figure Japan Sales Revenue Market Share of Biosimilar Drug by Companies in 2011
Figure Japan Sales Revenue Market Share of Biosimilar Drug by Companies in 2015
Figure Japan Sale Price (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure Japan Sale Price (USD/Dose) of Biosimilar Drug by Types in 2015
Table Japan Sale Price (USD/Dose) of Biosimilar Drug by Applications 2011-2016
Figure Japan Sale Price (USD/Dose) of Biosimilar Drug by Applications in 2015
Table Japan Sale Price (USD/Dose) of Biosimilar Drug by Companies 2011-2016
Figure Japan Sale Price (USD/Dose) of Biosimilar Drug by Companies in 2015
Table Japan Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table Japan End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications
Figure China Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure China Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Table China Market Size (Volume) (K Dose) of Biosimilar Drug by Types 2011-2016
Figure China Market Size (Volume) Share of Biosimilar Drug by Types in 2011
Figure China Market Size (Volume) Share of Biosimilar Drug by Types in 2015
Table China Market Size (Value) (M USD) of Biosimilar Drug by Types 2011-2016
Figure China Market Size (Value) Share of Biosimilar Drug by Types in 2011
Figure China Market Size (Value) Share of Biosimilar Drug by Types in 2015
Table China Market Size (Volume) (K Dose) of Biosimilar Drug by Applications 2011-2016
Figure China Market Size (Volume) Share of Biosimilar Drug by Applications in 2011
Figure China Market Size (Volume) Share of Biosimilar Drug by Applications in 2015
Table China Market Size (Value) (M USD) of Biosimilar Drug by Applications 2011-2016
Figure China Market Size (Value) Share of Biosimilar Drug by Applications in 2011
Figure China Market Size (Value) Share of Biosimilar Drug by Applications in 2015
Table China Sales Volume (K Dose) of Biosimilar Drug by Companies 2011-2016
Table China Sales Volume Market Share of Biosimilar Drug by Companies 2011-2016
Figure China Sales Volume Market Share of Biosimilar Drug by Companies in 2011
Figure China Sales Volume Market Share of Biosimilar Drug by Companies in 2015
Table China Sales Revenue (M USD) of Biosimilar Drug by Companies 2011-2016
Table China Sales Revenue Market Share of Biosimilar Drug by Companies 2011-2016
Figure China Sales Revenue Market Share of Biosimilar Drug by Companies in 2011
Figure China Sales Revenue Market Share of Biosimilar Drug by Companies in 2015
Figure China Sale Price (USD/Dose) of Biosimilar Drug by Types 2011-2016
Figure China Sale Price (USD/Dose) of Biosimilar Drug by Types in 2015
Table China Sale Price (USD/Dose) of Biosimilar Drug by Applications 2011-2016
Figure China Sale Price (USD/Dose) of Biosimilar Drug by Applications in 2015
Table China Sale Price (USD/Dose) of Biosimilar Drug by Companies 2011-2016
Figure China Sale Price (USD/Dose) of Biosimilar Drug by Companies in 2015
Table China Regional Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table China End Users with Contact Information and Consumption Volume of Biosimilar Drug by Applications
Table Hospira Information List
Figure Biosimilar Drug Picture and Specifications of Hospira
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Hospira 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Hospira 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Hospira 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Hospira 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Hospira 2011-2016
Table Sandoz Information List
Figure Biosimilar Drug Picture and Specifications of Sandoz
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Sandoz 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Sandoz 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Sandoz 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Sandoz 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Sandoz 2011-2016
Table Teva Pharmaceutical Industries Information List
Figure Biosimilar Drug Picture and Specifications of Teva Pharmaceutical Industries
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Teva Pharmaceutical Industries 2011-2016
Table Pfizer Information List
Figure Biosimilar Drug Picture and Specifications of Pfizer
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Pfizer 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Pfizer 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Pfizer 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Pfizer 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Pfizer 2011-2016
Table Merck Sharp & Dohme Information List
Figure Biosimilar Drug Picture and Specifications of Merck Sharp & Dohme
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Merck Sharp & Dohme 2011-2016
Table Celltrion Information List
Figure Biosimilar Drug Picture and Specifications of Celltrion
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Celltrion 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Celltrion 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Celltrion 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Celltrion 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Celltrion 2011-2016
Table Amgen Information List
Figure Biosimilar Drug Picture and Specifications of Amgen
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Amgen 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Amgen 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Amgen 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Amgen 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Amgen 2011-2016
Table Biogen Information List
Figure Biosimilar Drug Picture and Specifications of Biogen
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Biogen 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Biogen 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Biogen 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Biogen 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Biogen 2011-2016
Table Mylan Information List
Figure Biosimilar Drug Picture and Specifications of Mylan
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Mylan 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Mylan 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Mylan 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Mylan 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Mylan 2011-2016
Table Biocon Information List
Figure Biosimilar Drug Picture and Specifications of Biocon
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Biocon 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Biocon 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Biocon 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Biocon 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Biocon 2011-2016
Table Dr. Reddy’s Laboratories Information List
Figure Biosimilar Drug Picture and Specifications of Dr. Reddy’s Laboratories
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Dr. Reddy’s Laboratories 2011-2016
Table Boehringer Ingelheim GmbH Information List
Figure Biosimilar Drug Picture and Specifications of Boehringer Ingelheim GmbH
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Boehringer Ingelheim GmbH 2011-2016
Table Intas Pharmaceuticals Information List
Figure Biosimilar Drug Picture and Specifications of Intas Pharmaceuticals
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Intas Pharmaceuticals 2011-2016
Table LG Life Sciences Information List
Figure Biosimilar Drug Picture and Specifications of LG Life Sciences
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of LG Life Sciences 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of LG Life Sciences 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of LG Life Sciences 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of LG Life Sciences 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of LG Life Sciences 2011-2016
Table Emcure Pharmaceuticals Information List
Figure Biosimilar Drug Picture and Specifications of Emcure Pharmaceuticals
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Emcure Pharmaceuticals 2011-2016
Table Probiomed Information List
Figure Biosimilar Drug Picture and Specifications of Probiomed
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Probiomed 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Probiomed 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Probiomed 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Probiomed 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Probiomed 2011-2016
Table Biosidus Information List
Figure Biosimilar Drug Picture and Specifications of Biosidus
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Biosidus 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Biosidus 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Biosidus 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Biosidus 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Biosidus 2011-2016
Table 3SBio Information List
Figure Biosimilar Drug Picture and Specifications of 3SBio
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of 3SBio 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of 3SBio 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of 3SBio 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of 3SBio 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of 3SBio 2011-2016
Table WOCKHARDT Information List
Figure Biosimilar Drug Picture and Specifications of WOCKHARDT
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of WOCKHARDT 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of WOCKHARDT 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of WOCKHARDT 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of WOCKHARDT 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of WOCKHARDT 2011-2016
Table Sun Pharmaceutical Industries Information List
Figure Biosimilar Drug Picture and Specifications of Sun Pharmaceutical Industries
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Sun Pharmaceutical Industries 2011-2016
Table Shanghai Fosun Pharmaceutical Information List
Figure Biosimilar Drug Picture and Specifications of Shanghai Fosun Pharmaceutical
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Shanghai Fosun Pharmaceutical 2011-2016
Table Qilu Pharmaceutical Information List
Figure Biosimilar Drug Picture and Specifications of Qilu Pharmaceutical
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Qilu Pharmaceutical 2011-2016
Table Allergan Information List
Figure Biosimilar Drug Picture and Specifications of Allergan
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Allergan 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Allergan 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Allergan 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Allergan 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Allergan 2011-2016
Table Dongbao Information List
Figure Biosimilar Drug Picture and Specifications of Dongbao
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Dongbao 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Dongbao 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Dongbao 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Dongbao 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Dongbao 2011-2016
Table Samsung Biologics Information List
Figure Biosimilar Drug Picture and Specifications of Samsung Biologics
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Samsung Biologics 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Samsung Biologics 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Samsung Biologics 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Samsung Biologics 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Samsung Biologics 2011-2016
Table Zydus Cadila. Information List
Figure Biosimilar Drug Picture and Specifications of Zydus Cadila.
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Zydus Cadila. 2011-2016
Table Dong-A Pharmaceutical Information List
Figure Biosimilar Drug Picture and Specifications of Dong-A Pharmaceutical
Table Biosimilar Drug Sales Volume (K Dose), Sales Revenue (M USD), Sale Price (USD/Dose) and Gross Margin of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Growth Rate of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Volume (K Dose) and Global Market Share of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Growth Rate of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Sales Revenue (M USD) and Global Market Share of Dong-A Pharmaceutical 2011-2016
Table Global Production (K Dose) of Biosimilar Drug by Regions 2011-2016
Table Global Production Market Share of Biosimilar Drug by Regions 2011-2016
Table Global Production Market Share of Biosimilar Drug by Regions in 2011
Table Global Production Market Share of Biosimilar Drug by Regions in 2015
Figure Global Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure Global Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure USA Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure USA Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure Europe Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure Europe Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure China Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure Japan Market Size (Volume) (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure Japan Market Size (Value) (M USD) and Growth Rate of Biosimilar Drug 2016-2021
Table Global Market Size (Volume) (K Dose) of Biosimilar Drug by Regions 2016-2021
Figure Global Market Size (Volume) Share of Biosimilar Drug by Regions in 2016
Figure Global Market Size (Volume) Share of Biosimilar Drug by Regions in 2021
Table Global Market Size (Value) (M USD) of Biosimilar Drug by Regions 2016-2021
Figure Global Market Size (Value) Share of Biosimilar Drug by Regions in 2016
Figure Global Market Size (Value) Share of Biosimilar Drug by Regions in 2021
Table Global Market Size (Volume) (K Dose) of Biosimilar Drug by Types 2016-2021
Figure Global Market Size (Volume) Share of Biosimilar Drug by Types in 2016
Figure Global Market Size (Volume) Share of Biosimilar Drug by Types in 2021
Table Global Market Size (Value) (M USD) of Biosimilar Drug by Types 2016-2021
Figure Global Market Size (Value) Share of Biosimilar Drug by Types in 2016
Figure Global Market Size (Value) Share of Biosimilar Drug by Types in 2021
Table USA Market Size (Volume) (K Dose) of Biosimilar Drug by Types 2016-2021
Figure USA Market Size (Volume) Share of Biosimilar Drug by Types in 2016
Figure USA Market Size (Volume) S


More Publications